STEVE HORRELL/SPL/Getty Images
STEVE HORRELL/SPL/Getty Images

$93,000

Per-patient cost of Provenge, a new anti-cancer vaccine that has been shown to prolong life in prostate cancer patients by four months. On Wednesday, a federal committee offered support for the treatment, which makes it likelier that Medicare will cover its cost. [via Wall Street Journal]

Related Topics: Medicare, prostate cancer, vaccination, Facts & Statistics, Numbers
  • Latest on Healthland

    Martin Barraud / Getty Images

    The Upside of Peer Pressure: Social Networks Help Kids Exercise More

    A new study found that the single biggest influence on kids’ physical activity levels was the exercise habits of their six closest friends.

    'The Demise of Guys': How Video Games And Porn Are Ruining A GenerationCNN Health

    Jeffrey Coolidge / Getty Images

    Memorial Day Food Safety: Tips for Handling Fruits and Veggies

    How to eat your fill of summer fruits and vegetables without getting sick from a food-borne illness.

blog comments powered by Disqus